Join
Live feed
·
PRReleasevia Quantisnow
Orphazyme A/S logo
ImmunityBio Inc. logo

CytRx Corporation Enters Into Securities Purchase Agreement for $10 Million With Healthcare-Focused Institutional Investor

ByQuantisnow·Wall Street's wire, on your screen.
ORPH· Orphazyme A/SIBRX· ImmunityBio Inc.
TechnologyHealth Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORPH (Orphazyme A/S), IBRX (ImmunityBio Inc.) and more on Quantisnow.